This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distributor. The contract, valued at $9,599.25, is for the delivery of the drug LONSURF 20 MG-8.19 MG TABLET 60S.
Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials, to DLA facilities supporting the Department of Defense worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
This award does not have a set-aside designation. Amerisourcebergen, as a for-profit organization, has demonstrated its competitive position in the federal pharmaceutical supply market through the receipt of these multiple high-value contracts with various government agencies.
Generated 8/5/24, 9:06 AM